These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33166868)

  • 21. Correlation between early postnatal body weight changes and lung ultrasound scores as predictors of bronchopulmonary dysplasia in preterm infants: A secondary analysis of a prospective study.
    Ghanem M; Zozaya C; Ibrahim J; Lee S; Mohsen N; Nasef N; Mohamed A
    Eur J Pediatr; 2024 May; 183(5):2123-2130. PubMed ID: 38363393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.
    Ehrenkranz RA; Walsh MC; Vohr BR; Jobe AH; Wright LL; Fanaroff AA; Wrage LA; Poole K;
    Pediatrics; 2005 Dec; 116(6):1353-60. PubMed ID: 16322158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks' gestation.
    Collins CT; Gibson RA; Makrides M; McPhee AJ; Sullivan TR; Davis PG; Thio M; Simmer K; Rajadurai VS;
    BMC Pediatr; 2016 Jun; 16():72. PubMed ID: 27250120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence, Severity Patterns and Risk Factors of Bronchopulmonary Dysplasia in Preterm Infants Younger than 32 Weeks of Gestation in a Tertiary Centre in Oman.
    Al Mandhari H; Khan A; Al Saadi A; AboAnza M; Rizvi SGA; Panchatcharam SM; Abdulatif M; Al Qassabi S; Quach S
    Sultan Qaboos Univ Med J; 2024 May; 24(2):259-267. PubMed ID: 38828256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphocyte-Specific Biomarkers Associated With Preterm Birth and Bronchopulmonary Dysplasia.
    Bhattacharya S; Mereness JA; Baran AM; Misra RS; Peterson DR; Ryan RM; Reynolds AM; Pryhuber GS; Mariani TJ
    Front Immunol; 2020; 11():563473. PubMed ID: 33552042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early postnatal additional high-dose oral vitamin A supplementation versus placebo for 28 days for preventing bronchopulmonary dysplasia or death in extremely low birth weight infants.
    Meyer S; Gortner L;
    Neonatology; 2014; 105(3):182-8. PubMed ID: 24434948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mortality after 36 weeks postmenstrual age of extremely preterm infants in neonatal care: The impact of growth impairment and bronchopulmonary dysplasia.
    Dassios T; Williams E; Hickey A; Bhat R; Greenough A
    Early Hum Dev; 2022 Aug; 171():105618. PubMed ID: 35759944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurodevelopmental outcomes of extremely preterm infants with bronchopulmonary dysplasia (BPD) - A retrospective cohort study.
    Nguyen KL; Fitzgerald DA; Webb A; Bajuk B; Popat H
    Paediatr Respir Rev; 2024 Jun; 50():23-30. PubMed ID: 38490918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Association between Early Gram-Negative Bacteria in Tracheal Aspirate Cultures and Severe Bronchopulmonary Dysplasia among Extremely Preterm Infants Requiring Prolonged Ventilation.
    Imanishi Y; Hirata K; Nozaki M; Mochizuki N; Hirano S; Wada K
    Am J Perinatol; 2023 Sep; 40(12):1321-1327. PubMed ID: 34359078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early inhaled nitric oxide in preterm infants <34 weeks with evolving bronchopulmonary dysplasia.
    Jiang Q; Gao X; Liu C; Chen D; Lin X; Xia S; Zhuang D; Yang C; Zhu W; Liu L; Chen C; Sun B
    J Perinatol; 2016 Oct; 36(10):883-9. PubMed ID: 27442155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bronchopulmonary dysplasia and postnatal growth following extremely preterm birth.
    Dassios T; Williams EE; Hickey A; Bunce C; Greenough A
    Arch Dis Child Fetal Neonatal Ed; 2021 Jul; 106(4):386-391. PubMed ID: 33334820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Microbiome of the Lower Respiratory Tract in Premature Infants with and without Severe Bronchopulmonary Dysplasia.
    Imamura T; Sato M; Go H; Ogasawara K; Kanai Y; Maeda H; Chishiki M; Shimizu H; Mashiyama F; Goto A; Momoi N; Hosoya M
    Am J Perinatol; 2017 Jan; 34(1):80-87. PubMed ID: 27240094
    [No Abstract]   [Full Text] [Related]  

  • 33. Early cardiac function and death, severe bronchopulmonary dysplasia and pulmonary hypertension in extremely preterm infants.
    Moore SS; De Carvalho Nunes G; Dancea A; Wutthigate P; Simoneau J; Beltempo M; Sant'Anna G; Altit G
    Pediatr Res; 2024 Jan; 95(1):293-301. PubMed ID: 37726544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating endothelial progenitor cells decrease in infants with bronchopulmonary dysplasia and increase after inhaled nitric oxide.
    Qi Y; Jiang Q; Chen C; Cao Y; Qian L
    PLoS One; 2013; 8(11):e79060. PubMed ID: 24244420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm Infants.
    Morrow LA; Wagner BD; Ingram DA; Poindexter BB; Schibler K; Cotten CM; Dagle J; Sontag MK; Mourani PM; Abman SH
    Am J Respir Crit Care Med; 2017 Aug; 196(3):364-374. PubMed ID: 28249118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decrease in incidence of bronchopulmonary dysplasia with erythropoietin administration in preterm infants: a retrospective study.
    Rayjada N; Barton L; Chan LS; Plasencia S; Biniwale M; Bui KC
    Neonatology; 2012; 102(4):287-92. PubMed ID: 22922736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluid status in the first 10 days of life and death/bronchopulmonary dysplasia among preterm infants.
    Soullane S; Patel S; Claveau M; Wazneh L; Sant'Anna G; Beltempo M
    Pediatr Res; 2021 Aug; 90(2):353-358. PubMed ID: 33824447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Sustained Inflations vs Intermittent Positive Pressure Ventilation on Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants: The SAIL Randomized Clinical Trial.
    Kirpalani H; Ratcliffe SJ; Keszler M; Davis PG; Foglia EE; Te Pas A; Fernando M; Chaudhary A; Localio R; van Kaam AH; Onland W; Owen LS; Schmölzer GM; Katheria A; Hummler H; Lista G; Abbasi S; Klotz D; Simma B; Nadkarni V; Poulain FR; Donn SM; Kim HS; Park WS; Cadet C; Kong JY; Smith A; Guillen U; Liley HG; Hopper AO; Tamura M;
    JAMA; 2019 Mar; 321(12):1165-1175. PubMed ID: 30912836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global incidence of bronchopulmonary dysplasia among extremely preterm infants: a systematic literature review.
    Siffel C; Kistler KD; Lewis JFM; Sarda SP
    J Matern Fetal Neonatal Med; 2021 Jun; 34(11):1721-1731. PubMed ID: 31397199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Respiratory management and bronchopulmonary dysplasia in extremely preterm infants: a comparison of practice between centres in Oxford and Melbourne.
    Sun S; Zivanovic S; Earnest A; Roehr CC; Tan K
    J Perinatol; 2022 Jan; 42(1):53-57. PubMed ID: 34987168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.